SLRX Stock Price | Salarius Pharmaceuticals Inc P/E, Revenue, EPS, & Forecasts

Salarius Pharmaceuticals Inc • SLRX

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Salarius Pharmaceuticals Inc

Ticker

SLRX

Trading on

NASDAQ

ISIN

US79400X4043

Industry

Biotechnology

Sector

Healthcare

CEO

Headquarters

2450 Holcombe Blvd., Houston, TX, United States, 77021

Employees

Website

salariuspharma.com

Salarius Pharmaceuticals, Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs. The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. Salarius Pharmaceuticals, Inc. is based in Houston, Texas.

Metrics

BasicAdvanced

Market cap

$5M

P/E ratio

EPS

-$24.24

Dividend Yield

0.00%

Beta

0.33

Forward P/E ratio

EBIDTA

$-5.6M

Ex dividend date

Price & volume

Market cap

$5M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

18.12

Price to book

1.19

Earnings

EPS

-$24.24

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-5.6M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

0.33

52-week High

$55.05

52-week Low

$0.71

50-day moving average

$2.94

200-day moving average

$9.08

Short ratio

0.12

Short %

7.98%

Management effectiveness

ROE (TTM)

-139.55%

ROA (TTM)

-69.91%

Profit margin

0.00%

Gross profit margin

$-15.8M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

-100.00%

Share stats

Outstanding Shares

5.9M

Float

5.5M

Insiders %

0.64%

Institutions %

5.25%

Analyst Insights & forecasts

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

$26.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$1.01

-$0.74

-36.49%

Q4 • 24Missed

-$1.02

-$1.03

1.38%

Q1 • 25Beat

-$0.45

-$1.02

55.88%

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-1M

-∞%

Q2 • 25

$0M

$-0.9M

-∞%

Q3 • 25

NaN%

-8.81%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$1.4M

$2.2M

159.57%

Q2 • 25

$6.1M

$1.8M

30.33%

Q3 • 25

337.76%

-16.81%

-81.00%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-0.9M

$-0.1M

$-0.9M

Q2 • 25

$-1.6M

$5.9M

$-1.6M

Q3 • 25

90.97%

-4,251.28%

90.97%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Salarius Pharmaceuticals Inc share?

Salarius Pharmaceuticals Inc shares are currently traded for undefined per share.

How many shares does Salarius Pharmaceuticals Inc have?

Salarius Pharmaceuticals Inc currently has 5.9M shares.

Does Salarius Pharmaceuticals Inc pay dividends?

No, Salarius Pharmaceuticals Inc doesn't pay dividends.

What is Salarius Pharmaceuticals Inc 52 week high?

Salarius Pharmaceuticals Inc 52 week high is $55.05.

What is Salarius Pharmaceuticals Inc 52 week low?

Salarius Pharmaceuticals Inc 52 week low is $0.71.

What is the 200-day moving average of Salarius Pharmaceuticals Inc?

Salarius Pharmaceuticals Inc 200-day moving average is $9.08.

Who is Salarius Pharmaceuticals Inc CEO?

The CEO of Salarius Pharmaceuticals Inc is -.

How many employees Salarius Pharmaceuticals Inc has?

Salarius Pharmaceuticals Inc has 2 employees.

What is the market cap of Salarius Pharmaceuticals Inc?

The market cap of Salarius Pharmaceuticals Inc is $5M.

What is the P/E of Salarius Pharmaceuticals Inc?

The current P/E of Salarius Pharmaceuticals Inc is null.

What is the EPS of Salarius Pharmaceuticals Inc?

The EPS of Salarius Pharmaceuticals Inc is -$24.24.

What is the PEG Ratio of Salarius Pharmaceuticals Inc?

The PEG Ratio of Salarius Pharmaceuticals Inc is 0.

What do analysts say about Salarius Pharmaceuticals Inc?

According to the analysts Salarius Pharmaceuticals Inc is considered a hold.